search

Daily Briefing June 21 – Israel sees COVID surge, PA rejects vaccine transfer

Tune in Sunday through Thursday to hear ToI editors and reporters quickly catch you up on what’s important today

Welcome to The Times of Israel’s Daily Briefing, your 15-minute audio update on what’s happening in Israel, the Middle East, and the Jewish world, from Sunday through Thursday.

Today’s panel comprises our health reporter Nathan Jeffay and Palestinian affairs correspondent Aaron Boxerman, along with host Amanda Borschel-Dan.

Israel is experiencing a minor surge in COVID cases. We discuss what the origins are and just how worrying this is.

Over the weekend Israel and the Palestinian Authority inked a deal with Pfizer for the transfer of some 1.4 million COVID vaccine doses from Israel to the PA. However, the Palestinians quickly rejected the soon-to-be-expired shots. What’s happening now?

Equally controversial is the Family Reunification amendment to the Citizenship Law, which was slated for a renewal vote this week. Boxerman gives background on the 2003 amendment, which limits the granting of citizenship to Palestinians married to Arab Israelis, and explains what’s at stake now.

And finally, we hear about interesting new research reaffirming the linkage of Vitamin D deficiency with poor results for those infected with the coronavirus.

Discussed articles include:

Government orders stepped-up COVID screening at airport, quarantine inspections

As virus infection rate rises once more, health experts say: Don’t panic

PA says it wants to renegotiate terms of vaccine deal with Israel, Pfizer

Three countries said to ask Israel for vaccine doses Palestinians don’t want

Lacking a majority, vote to extend Palestinian family reunification ban delayed

1 in 4 COVID patients hospitalized while vitamin D deficient die – Israeli study

Subscribe to The Times of Israel Daily Briefing on iTunesSpotifyPlayerFM, Google Play, or wherever you get your podcasts.

read more:
comments
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed